| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |